These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15776270)

  • 1. [Urosepsis. Current therapy and diagnosis].
    Book M; Lehmann LE; Schewe JC; Weber S; Stüber F
    Urologe A; 2005 Apr; 44(4):413-22; quiz 423-4. PubMed ID: 15776270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urosepsis--Etiology, Diagnosis, and Treatment.
    Dreger NM; Degener S; Ahmad-Nejad P; Wöbker G; Roth S
    Dtsch Arztebl Int; 2015 Dec; 112(49):837-47; quiz 848. PubMed ID: 26754121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urosepsis: Overview of the Diagnostic and Treatment Challenges.
    Wagenlehner FME; Pilatz A; Weidner W; Naber KG
    Microbiol Spectr; 2015 Oct; 3(5):. PubMed ID: 26542042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urosepsis. Update on diagnosis and treatment].
    Wagenlehner FM; Alidjanov J; Pilatz A
    Urologe A; 2016 Apr; 55(4):454-9. PubMed ID: 27003569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal management of urosepsis from the urological perspective.
    Wagenlehner FM; Weidner W; Naber KG
    Int J Antimicrob Agents; 2007 Nov; 30(5):390-7. PubMed ID: 17728107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary tract infections in adults.
    Cohn EB; Schaeffer AJ
    ScientificWorldJournal; 2004 Jun; 4 Suppl 1():76-88. PubMed ID: 15349531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Urosepsis in 2018.
    Bonkat G; Cai T; Veeratterapillay R; Bruyère F; Bartoletti R; Pilatz A; Köves B; Geerlings SE; Pradere B; Pickard R; Wagenlehner FME
    Eur Urol Focus; 2019 Jan; 5(1):5-9. PubMed ID: 30448051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management for urosepsis.
    Wagenlehner FM; Lichtenstern C; Rolfes C; Mayer K; Uhle F; Weidner W; Weigand MA
    Int J Urol; 2013 Oct; 20(10):963-70. PubMed ID: 23714209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis.
    Wagenlehner FM; Weidner W; Naber KG
    Clin Pharmacokinet; 2007; 46(4):291-305. PubMed ID: 17375981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nosocomial urinary tract infection in adults].
    Hug BL; Flückiger U; Widmer AF
    Internist (Berl); 2006 Nov; 47(11):1151-62. PubMed ID: 17048018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urosepsis--from the view of the urologist.
    Wagenlehner FM; Pilatz A; Weidner W
    Int J Antimicrob Agents; 2011 Dec; 38 Suppl():51-7. PubMed ID: 21993485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary tract infections and urosepsis: a physician's guide.
    Zeinati S; Khauli RB
    J Med Liban; 2004; 52(4):189-93. PubMed ID: 16432980
    [No Abstract]   [Full Text] [Related]  

  • 13. [Urosepsis: pathophysiology, diagnosis, and management-an update].
    Stangl F; Wagenlehner F; Schneidewind L; Kranz J
    Urologie; 2024 Jun; 63(6):543-550. PubMed ID: 38639782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varying international practices regarding the evaluation of febrile young infants.
    Umana E; Waterfield T
    Arch Dis Child; 2021 Nov; 106(11):1037-1038. PubMed ID: 34526296
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic challenges of urosepsis.
    Wagenlehner FM; Pilatz A; Naber KG; Weidner W
    Eur J Clin Invest; 2008 Oct; 38 Suppl 2():45-9. PubMed ID: 18826481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vesicorenal reflux].
    Fisch M
    Urologe A; 2005 Jun; 44(6):W683-92; quiz W693. PubMed ID: 15905988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urosepsis: from the intensive care viewpoint.
    Marx G; Reinhart K
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S79-84. PubMed ID: 18053691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urosepsis].
    Moen H; von der Lippe E; Tveter KJ
    Tidsskr Nor Laegeforen; 1997 Mar; 117(7):959-62. PubMed ID: 9103008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Barriers to guideline adherence : Identification of barriers to guideline adherence using a survey on the AWMF S3 guideline epidemiology, diagnosis, treatment, and management of uncomplicated bacterial, community-acquired urinary tract infections in adult patients].
    Kranz J; Schlager D; Mühlstädt S; Nagler J; Wagenlehner FME; Schneidewind L
    Urologe A; 2019 Sep; 58(9):1019-1028. PubMed ID: 30623216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections and urolithiasis: current clinical evidence in prophylaxis and antibiotic therapy.
    Zanetti G; Paparella S; Trinchieri A; Prezioso D; Rocco F; Naber KG
    Arch Ital Urol Androl; 2008 Mar; 80(1):5-12. PubMed ID: 18533618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.